Jefferies Financial Group Analysts Give Fresenius SE & Co. KGaA (FRA:FRE) a €33.00 Price Target

Jefferies Financial Group set a €33.00 ($35.48) target price on Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) in a report issued on Tuesday morning, Borsen Zeitung reports.

Several other equities analysts have also recently weighed in on the stock. Warburg Research set a €34.00 ($36.56) price objective on shares of Fresenius SE & Co. KGaA in a research note on Friday, March 10th. JPMorgan Chase & Co. set a €31.90 ($34.30) price objective on shares of Fresenius SE & Co. KGaA in a research note on Wednesday, February 22nd. Credit Suisse Group set a €26.00 ($27.96) price objective on shares of Fresenius SE & Co. KGaA in a research note on Tuesday. UBS Group set a €32.50 ($34.95) price objective on shares of Fresenius SE & Co. KGaA in a research note on Tuesday, February 28th. Finally, Deutsche Bank Aktiengesellschaft set a €22.00 ($23.66) price objective on shares of Fresenius SE & Co. KGaA in a research note on Thursday, March 9th.

Fresenius SE & Co. KGaA Stock Up 0.4 %

Shares of FRA FRE opened at €23.93 ($25.73) on Tuesday. The firm’s 50-day moving average price is €27.13 and its 200-day moving average price is €25.16. Fresenius SE & Co. KGaA has a 52-week low of €60.16 ($64.69) and a 52-week high of €80.00 ($86.02).

Fresenius SE & Co. KGaA Company Profile

(Get Rating)

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.